 |
Recent Publications Supporting Clinical Trials
William E. Boden, M.D., et. al.
Optimal Medical Therapy with or without PCI for Stable Coronary Disease.
NEJM. 2007, April 12;356(15):1503-1516
Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP.
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Arch Intern Med. 2002 Jul 22;162(14):1568-76.
Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.
Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
JAMA. 2002 May 22-29;287(20):2668-76.
Kashyap ML, McGovern ME, Berra K, Guyton JR, Kwiterovich PO, Harper WL, Toth PD, Favrot LK, Kerzner B, Nash SD, Bays HE, Simmons PD.
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia.
Am J Cardiol. 2002 Mar 15;89(6):672-8.
Lobo RA, Bush T, Carr BR, Pickar JH.
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
Fertil Steril. 2001 Jul;76(1):13-24.
Archer DF, Dorin M, Lewis V, Schneider DL, Pickar JH.
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.
Fertil Steril. 2001 Jun;75(6):1080-7.
Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH.
Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
Fertil Steril. 2001 Jun;75(6):1065-79.
Goldberg RB, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E.
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.
Circulation. 1998 Dec 8;98(23):2513-9.
Recent CLCS Research Publications
Nowatzke WL, Landt M, Smith C, Wilhite T, Canter C and Luchtman-Jones L.
Whole Blood International Normalization Ratio Measurements in Children Using Near-Patient Monitors.
J Pediat Hemat/Oncol 2003;25(4):33-38.
Cole TG, Nowatzke WL, Bisgaier CL, Krause BR.
Method-dependent changes in "HDL-cholesterol" with recombinant apolipoprotein A-I(Milano) infusion in healthy volunteers.
Clin Chem. 2002;48(4):680-1.
Nowatzke WL, Parvin CA, Scott MG, Hock K, Cole TG.
Correction of positive bias of the Roche Tina-quant II hemoglobin A1c (HbA1c) assay at low HbA1c percentages.
Clin Chem. 2001 May;47(5):976-8.
Cole TG, Ferguson CA, Gibson DW, Nowatzke WL.
Optimization of beta-quantification methods for high-throughput applications.
Clin Chem. 2001 Apr;47(4):712-21.
Kroll MH, Cole TG, Rifai N, Cooper G, Warnick GR, Jialal I.
Standardization of lipoprotein reporting.
Am J Clin Pathol. 2000 Nov;114(5):696-702.
Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E.
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
Circulation. 2000 Oct 17;102(16):1886-92.
Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM.
Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
Ann Neurol. 2000 Aug;48(2):201-10.
Nauck M, Graziani MS, Bruton D, Cobbaert C, Cole TG, Lefevre F, Riesen W, Bachorik PS, Rifai N.
Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation.
Clin Chem. 2000 Apr;46(4):506-14.
Nauck M, Graziani MS, Jarausch J, Bruton D, Cobbaert C, Cole TG, Colella F, Lefevre F, Gillery P, Haas B, Law T, Konig M, Macke M, Marz W, Meier C, Riesen W, van Vliet M, Wieland H, Rifai N.
A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United States.
Clin Chem Lab Med. 1999 Nov-Dec;37(11-12):1067-76.
Kimberly MM, Leary ET, Cole TG, Waymack PP.
Selection, validation, standardization, and performance of a designated comparison method for HDL-cholesterol for use in the cholesterol reference method laboratory network.
Clin Chem. 1999 Oct;45(10):1803-12.
Wu J, Kim J, Li Q, Kwok PY, Cole TG, Cefalu B, Averna M, Schonfeld G.
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia.
J Lipid Res. 1999 May;40(5):955-9.
Cole TG, Parikh N.
High-throughput measurement of oxidizability of low-density lipoproteins suitable for use in clinical trials.
Clin Chem. 1999 May;45(5):696-9.
Wu AH, Contois JH, Cole TG.
Reflex testing I: algorithm for lipid and lipoprotein measurement in coronary heart disease risk assessment.
Clin Chim Acta. 1999 Feb;280(1-2):181-93.
Rifai N, Cole TG, Iannotti E, Law T, Macke M, Miller R, Dowd D, Wiebe DA.
Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay.
Clin Chem. 1998 Jul;44(7):1452-8.
Angelopoulos TJ, Seip RL, Cole TG.
Effect of short-term recombinant growth hormone administration on plasma lipoproteins in elderly adults.
Gerontology. 1998;44(4):228-31.
Cole TG.
The role of the central clinical laboratory in the development of drugs for the treatment of cardiovascular disease by the modification of lipoprotein concentrations.
Am J Cardiol. 1998 Apr 23;81(8A):75F-77F. Review.
Sacks FM, Moye LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E.
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.
Circulation. 1998 Apr 21;97(15):1446-52.
Zhang DJ, LaRue S, Miller WG, Cole TG.
Performance of predispensed reagent and noncentrifugation methods for high-density lipoprotein cholesterol measurement.
Arch Pathol Lab Med. 1997 Sep;121(9):938-47.
McNamara JR, Leary ET, Ceriotti F, Boersma-Cobbaert CM, Cole TG, Hassemer DJ, Nakamura M, Packard CJ, Seccombe DW, Kimberly MM, Myers GL, Cooper GR.
Point: status of lipid and lipoprotein standardization.
Clin Chem. 1997 Aug;43(8 Pt 1):1306-10.
Seip RL, Mair K, Cole TG, Semenkovich CF.
Induction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transient.
Am J Physiol. 1997 Feb;272(2 Pt 1):E255-61.
Back to the top of the Page |
|
|
|